Naturally Acquired Humoral Immunity Against Malaria.

Front Immunol

Department of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.

Published: June 2021

Malaria remains a significant contributor to the global burden of disease, with around 40% of the world's population at risk of infections. The development of an effective vaccine against the malaria parasite would mark a breakthrough in the fight to eradicate the disease. Over time, natural infection elicits a robust immune response against the blood stage of the parasite, providing protection against malaria. In recent years, we have gained valuable insight into the mechanisms by which IgG acts to prevent pathology and inhibit parasite replication, as well as the potential role of immunoglobulin M (IgM) in these processes. Here, we discuss recent advances in our understanding of the mechanisms, acquisition, and maintenance of naturally acquired immunity, and the relevance of these discoveries for the development of a potential vaccine against the blood stage of .

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658415PMC
http://dx.doi.org/10.3389/fimmu.2020.594653DOI Listing

Publication Analysis

Top Keywords

naturally acquired
8
blood stage
8
acquired humoral
4
humoral immunity
4
malaria
4
immunity malaria
4
malaria malaria
4
malaria remains
4
remains contributor
4
contributor global
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!